<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01282983</url>
  </required_header>
  <id_info>
    <org_study_id>IKEA2010</org_study_id>
    <nct_id>NCT01282983</nct_id>
  </id_info>
  <brief_title>Study of Digestive Tolerance of Orange Juice With Fibers</brief_title>
  <official_title>Study of Digestive Tolerance of Orange Juice With Fibers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dietary fiber (commonly called bulk or roughage) is the edible nondigestible component of&#xD;
      carbohydrate and lignin naturally found in plant food; however, bacteria in the lower gut may&#xD;
      metabolize part of it. Epidemiological studies have found that fiber intake in the population&#xD;
      is below the suggested recommendations. The beneficial effects of the fibers in human health&#xD;
      are recognized. The regular intake of dietary fiber has an important role in the intestinal&#xD;
      function increasing the intestinal fecal and reducing the transit time along the intestine;&#xD;
      collaborates with the LDL-cholesterol plasmatic reduction by increasing fecal excretion of&#xD;
      cholesterol and bile acids, decreases postprandial glucose in healthy, diabetics and insulin&#xD;
      resistant people, reduces the risk for developing certain cancers, promotes satiety, helps&#xD;
      with weight loss, and exerts immunomodulatory effect. However, fiber intake may be associated&#xD;
      with adverse effects such as flatulence, bloating, cramps, and daily consumption of orange&#xD;
      juice to bring digestive problems associated with acidity and heartburn, epigastric burning.&#xD;
      Then it becomes of interest to study the tolerance of a new orange juice product fortified&#xD;
      with mixed fibers (fructooligosaccharides, resistant dextrin, polydextrose and lactulose).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Monocentric, double blind, randomized, two parallel arms controlled placebo study. 200&#xD;
      healthy women from 18 to 45 years old, without functional digestive disorders or diagnosed&#xD;
      digestive disease will take part in the study. The study consists of 21 days consumption of&#xD;
      Orange juice. The participants will be randomized in two groups: placebo (Orange juice&#xD;
      without fiber - control) and study group (Orange juice fortified with fiber mix). In both&#xD;
      groups, the volunteers will be instructed to consume 200ml of juice twice a day (1 pack of&#xD;
      200ml at lunch and one at dinner).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">February 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of stool - Chart</measure>
    <time_frame>Frequency of stool - Chart</time_frame>
    <description>Bristol scale with classification type 1 to type 7 will be used for self-information on daily frequency of bowel movements and consistency of the feces.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Unwanted symptoms classification</measure>
    <time_frame>Unwanted symptoms classification</time_frame>
    <description>The daily graduation of nuisance for abdominal pain, flatulence, abdominal distension, nausea and vomiting using the classification for unwanted symptoms, with 4-point scale, after 3 weeks consumption of product with the information obtained with the standard orange juice consumption from the participant diary</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Digestive Alteration [PE]</condition>
  <arm_group>
    <arm_group_label>fiber</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fiber</intervention_name>
    <description>The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) with 4grams of fiber in each pack.</description>
    <arm_group_label>fiber</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) without fiber.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy&#xD;
&#xD;
          -  Tolerate the intake of orange juice routinely (at least twice/month)&#xD;
&#xD;
          -  Do not use antibiotics, industrial fibers or supplements containing industrialized&#xD;
             fibers, prebiotics and probiotics for 30 days before the start of the study&#xD;
&#xD;
          -  BMI between 18,5 a 29,9 Kg/m2&#xD;
&#xD;
          -  Body weight stable during the last two months&#xD;
&#xD;
          -  Able to have good communication with the researcher&#xD;
&#xD;
          -  Understand and agree with the rules of the study&#xD;
&#xD;
          -  Making use of some contraceptive method&#xD;
&#xD;
          -  Non-smokers (less than five cigarettes/day)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Illiterate&#xD;
&#xD;
          -  Severe alcoholics&#xD;
&#xD;
          -  Allergy to orange and its juice&#xD;
&#xD;
          -  Any other allergy or food intolerance&#xD;
&#xD;
          -  Disease or disorder of the upper digestive tract diagnosed and treated in the last&#xD;
             twelve months&#xD;
&#xD;
          -  Inflammatory bowel diseases&#xD;
&#xD;
          -  Irritable bowel syndrome&#xD;
&#xD;
          -  To have diarrhea (three liquid evacuations a day)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Lactation&#xD;
&#xD;
          -  Any history of eating disorder&#xD;
&#xD;
          -  Declared diseases:&#xD;
&#xD;
               -  Renal insufficiency&#xD;
&#xD;
               -  Hepatic Insufficiency&#xD;
&#xD;
               -  Chronic Heart Failure&#xD;
&#xD;
               -  Other disease which in the opinion of the investigator might be inconsistent with&#xD;
                  the study&#xD;
&#xD;
          -  Be in dialysis process&#xD;
&#xD;
          -  Chronic renal failure&#xD;
&#xD;
          -  History or evidence of organic disease of the gastrointestinal tract&#xD;
&#xD;
          -  History of cancer within five previous years (except basal cell carcinoma well treated&#xD;
             or cervical carcinoma in situ)&#xD;
&#xD;
          -  History or evidence of metabolic disturbs&#xD;
&#xD;
          -  History of gastric surgery intervention (except appendectomy)&#xD;
&#xD;
          -  Being under some weight loosing process or diet&#xD;
&#xD;
          -  Refuse to sign the Informed Consent Term&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan L Waitzberg, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lilian M Horie, MsC RD</last_name>
    <email>mikahorie@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dan L Waitzberg, MD PhD</last_name>
    <email>dan@ganep.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan L Waitzberg, MD PhD</last_name>
      <email>dan@ganep.com.br</email>
    </contact>
    <contact_backup>
      <last_name>Lilian M Horie, RD MsC</last_name>
      <email>mikahorie@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Dan L Waitzberg, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana P Muniz Pereira, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cecilia Jardini Marques, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Glaucia M Shiroma, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juliana Lopes Frias, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lidiane A Catalani, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lilian M Horie, RD MsC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Liria Nubia Alvarenga, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Carolina Gonçalves Dias, RD MsC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Cláudia Ortolani, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria de Lourdes Teixeira da Silva, MD MsC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Manuela Ferreira Alves, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Priscila Carasin Garla, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ricardo Alexandre Garib, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <study_first_submitted>January 20, 2011</study_first_submitted>
  <study_first_submitted_qc>January 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2011</study_first_posted>
  <last_update_submitted>January 24, 2011</last_update_submitted>
  <last_update_submitted_qc>January 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dan Linetzky Waitzberg - Professor</name_title>
    <organization>University of São Paulo</organization>
  </responsible_party>
  <keyword>fiber</keyword>
  <keyword>orange juice</keyword>
  <keyword>digestive symptom</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

